May 16, 2019

GRYT Health Announces Formation of Advisory Board

ROCHESTER, N.Y., May 16, 2019 – GRYT Health (“GRYT”), an award-winning, mobile app-based social community for people affected by cancer, today announced the formation of its advisory board to provide strategic counsel as the Company continues to execute its business strategy. 

“Together, we are moving healthcare forward with GRYT. I am honored to assemble this advisory board of outstanding individuals with exceptional track records as changemakers in each of their respective fields,” said Dave Fuehrer, CEO of GRYT Health. “Their extensive experience working with the cancer community will serve as a great resource to the GRYT team as we grow our business. These healthcare disruptors have made a significant impact on our industry and their guidance and contributions will be invaluable to furthering GRYT’s mission of connecting people affected by cancer with each other and to information that empowers them to live on their own terms.”

GRYT’s new strategic advisors include:

  • Catherine Benedict, Ph.D.: Research Advisor. Catherine is a licensed clinical psychologist and behavioral science researcher, specializing in adolescent and young adult cancer survivorship. She is an assistant professor within the Stanford University School of Medicine and works within the Stanford Cancer Institute to build clinical programs addressing cancer survivorship needs. Broadly, the goal of her work is to improve cancer survivorship through a better understanding of survivors’ long-term difficulties, unmet needs, and preferences for support, and through the development of evidence-based patient resources and interventions. This research has been funded by the National Cancer Institute. Another aspect of Catherine’s work aims to improve clinicians’ and researchers’ engagement with patients to guide clinical and research initiatives that respect and reflect the preferences and priorities of the young adult cancer community. Catherine is also a board member to Stupid Cancer, volunteer and grant reviewer for The Samfund, and advisory council member for the Alliance for Fertility Preservation.
  • Terry Cross: Veteran Angel investor and entrepreneur. While Terry has served on many boards over the years, his current board memberships include: RealKidz; PureEntropy as Chairman; MIST Innovations as Chairman; and Monarch Antenna, a Delphi Corp. spinout. Terry serves as the first Executive in Residence for Entrepreneurship at The School of Business Administration at Wayne State University in Detroit, MI, where he administers the prestigious Adams Entrepreneurial Fellowship and received the 2005 Distinguished Alumni Award. Terry was a co-founder of Sonoma Photonics, which was eventually sold to Lockheed-Martin. He was a founding investor in three startups from MIT’s tech transfer department and served on MIT’s Laboratory for Manufacturing and Productivity. In September of 2007, he was named to the Task Force for A World Financial Center by the Korea Advanced Institute of Science and Technology. Since 2002, he has mentored over 50 company founders in Southeast Michigan and has been instrumental in helping entrepreneurs raise in excess of $100 million of capital funding.
  • Ty Curran: Chairman of Harrison & Star and Biolumina. In his current role, Ty leads and motivates a growing team that always gives 110 percent to its clients. And, like a chief of surgery who’d rather be in the OR than behind a desk, Ty enjoys nothing better than immersing himself in a strategic challenge – and helping a client score a victory for the brand. Prior to Harrison & Star, Ty was Managing Director at NCI Communications. In his career, Ty has helped build brands and portfolios for Genentech, Roche, Novartis, Merck, Aventis, and Gilead. Ty has extensive oncology experience working on brands such as Avastin, Taxotere, Erivedge, Zelboraf, Zometa, Herceptin, and Femara. He is also on the National Advisory Board for the Family Reach Foundation.
  • Ellis Emerson: Ellis is a mother, runner, and cancer survivor who was diagnosed with Stage 3 melanoma in October 2017, right after her 32nd birthday. After her diagnosis, Ellis did not want to let one second of her life get away from her. In a little over a year, Ellis had thrown the first pitch at a Major League Baseball game, went cliff jumping in Puerto Rico, took a flying lesson in Iceland, and learned white water kayaking in New Zealand. In July of 2018, she ran 135 miles across Death Valley California as part of the Badwater Ultramarathon, often considered one of the world’s most challenging races. Ellis believes that “our experiences, while unique, are not different.” Sharing our stories is what brings people together and a community makes all the difference. Ellis shares her personal story to help others on her website, www.cancerpurgatory.com.
  • Shwen Gwee: Co-Founder and General Manager/Head of Open Innovation, Novartis Biome. Shwen is a recognized pioneer in digital strategy and innovation within the biopharma industry who was named a Top 40 “Healthcare Transformer” by MM&M in 2015 and a PR Week and MM&M "Health Influencer 50" in 2017 & 2018. He sits on various advisory boards, including Google (Healthcare), SXSW (Health), MM&M Healthcare Transformers, conversationHEALTH and the Digital Health Coalition. Shwen is regularly featured in industry publications and speaking events and chairs the Social Innovation Day for the Digital Pharma Series. In 2017, he spoke on Innovation in Healthcare at the prestigious Cannes Lions Health festival. Shwen is very involved in the health tech startup community; he organizes and participates in several startup boot camps and pitch contests, and plays an active role running healthcare hackathons as part of the MIT Hacking Medicine team.
  • Kathleen Griffin: Executive Director, Customer & Digital Engagement at Syneos. At Syneos, Kate identifies opportunities to harness data and technology to improve clinical trial execution and commercial success. She monitors the digital health environment, support business development efforts and looks for ways to partner across the organization. Prior to her strategic business role, she served as an Executive Director at INC Research and was responsible for IT strategy, communication and business relationship management. Kate was a founder of AVOS Life Sciences, a management consulting firm in the biopharmaceutical industry. Her industry experience includes holding several strategic development roles at Quintiles Transnational and efforts supporting pharmaceutical practice initiatives at IBM’s Wilkerson Group.
  • Kamala Maddali, DVM Ph.D.: Dr. Maddali is a global precision medicine executive with deep healthcare experience at large global companies including Merck and Co, Quintiles, Quest Diagnostics, and Cancer Genetics. As an ongoing warrior with multiple sclerosis, Dr. Maddali’s vision is to “educate global communities with hope from science and innovation,” which she hopes will foster awareness towards precision treatments and early disease diagnosis and prevention. She is a board member for several U.S. patient advocacy organizations and serves as an executive advisor for healthcare technology companies focused on artificial intelligence, blockchain genomics, nutraceuticals, bioinformatics, and biomarker driven drug targets. Dr. Maddali was the recipient of the 2016 NJBiz Healthcare Heroes Finalist Award and in 2019, she was awarded “Women Empowerment in Healthcare” by North American Indian Association for her contributions to innovation in healthcare.

ABOUT GRYT HEALTH

GRYT Health is an award-winning, social community and research platform founded by cancer survivors and caregivers. Through GRYT’s technology, people affected by cancer are able to connect to others with similar experiences, access information that is tailored to their specific needs/diagnosis and collaborate with the world's largest pharmaceutical companies to provide insights that help these firms improve quality of care.

GRYT’s community of patients, survivors, medical professionals, researchers and advocates, extending across all 50 states in the U.S. and in more than 100 countries worldwide, have participated in almost one million interactions to date. The company's research initiative, The GRYT Project, bridges the communication gap that has traditionally prevented the cancer community and industry from optimizing care through an equal partnership. GRYT values and partners with socially-conscious brands and brand experiences that inspire people to live according to their own standards. The company is headquartered in Rochester, NY. For more information, please visit www.grythealth.com. To download the app, please visit www.grythealth.com/app.To join The GRYT Project, please visit www.grythealth.com/the-gryt-project.

MEDIA CONTACT:

Vikki Christian
424-610-1241
vikki@grythealth.com

September 12, 2018

GRYT Health and Omnicom Group Announce Strategic Partnership to Increase Collaboration and Innovation between the Cancer Community and Industry

Partnership Accelerates Ability to Use Real-World Data to Develop Solutions that Reflect Patient Values and Preferences
Read more

June 2, 2018

GRYT Health’s Aerial Donovan Named Among Nation’s Top 40 Under 40 in Cancer

ROCHESTER, NY – Aerial Donovan, of Chicago, IL was recently named one of the nation’s top “40 Under 40 in Cancer.” The award, which was presented during a cocktail reception on June 2 in Chicago, was created by The Lynx Group™ and McGivney Global Advisors, as a means of celebrating the contributions that individuals under the age of 40 are making to improve the lives of those affected by cancer.

Donovan serves as Program Director for GRYT Health and has been instrumental in leading the organization’s efforts to increase programs and support for cancer patients around the world.

“It’s such an honor to be nominated, and selected for this award,” says Donovan. “Empowering people with the information they need to make decisions about their care and disease has been both rewarding and eye-opening. I’ve been grateful for the opportunity to meet this need.”

Nominations for the 40 Under 40 in Cancer award came from across the country and represented the following categories: clinical and patient care; biopharma, diagnostics and devices; research, science and technology; government, regulatory and payer; and patient, advocacy and policy. Members of the 2018 inaugural class were selected by a panel of judges.

"Early-career leaders in oncology — clinicians, researchers, business people, advocates — are making an enormous impact on patients and the cancer community, but many of these individuals have not had the opportunity to be widely recognized,” says McGivney Global Advisors Partner and cancer survivor Jennifer Hinkel. “40 under 40 in Cancer is an effort to highlight the contributions of these rising stars."

“These individuals are tomorrow’s driving force in innovation,” adds Brian Tyburski, President and CEO, The Lynx Group™. “Their achievements are crucial, well deserved, and should be applauded by all. We’re proud to partner with McGivney Global Advisors in honoring these 40 individuals for their outstanding achievements and contributions within their respective roles in the cancer continuum.”

More information about the award, nomination process and the “40 Under 40 in Cancer” awards ceremony and recipients can be found at 40under40incancer.com.

 

About McGivney Global Advisors LLC
McGivney Global Advisors is an expert consultancy for biopharma companies that was founded by William T. McGivney, PhD, former longtime CEO of National Comprehensive Cancer Network (NCCN) and former Vice President, Clinical and Coverage Policy for Aetna Health Plans. McGivney Global Advisors is distinguished as a consulting firm by its focus on bringing real-world expertise from leaders in guidelines, pathways/compendia, health policy, pharmaceutical reimbursement and market access, and cancer care delivery to decision-makers in pharma/biotech companies, investment houses and national associations. McGivney Global Advisors works with clients to identify the real issues impacting their businesses, provide in-depth and actionable analyses, and develop impactful strategies to facilitate optimal positioning for the success of innovative products. In addition to Dr. McGivney, the firm's leadership includes Jennifer Hinkel, MSc, Partner, an expert in health economics, oncology market access, and blockchain applications in health care. For more information, please visit mcgivneyglobal.com.

 

About The Lynx Group

The Lynx Group is a rapidly growing global strategic alliance of medical communications and education companies. Through its unique business model, The Lynx Group strives to provide pivotal and contemporary information and education for all stakeholders in healthcare. Visit thelynxgroup.com for more information.

 

####

MEDIA CONTACT:

GRYT Health:

Vikki Christian, 424-610-1241
vikki@grythealth.com

May 16, 2018

GRYT Health’s App Wins 2018 Appy Award for “Best Non-Profit App”

The GRYT App Provides Instant, Anonymous Peer Support and Tailored Information to Anyone Impacted by Cancer

ROCHESTER, N.Y., May 15, 2018 – GRYT Health, a digital health start-up with a social purpose, is pleased to announce that its GRYT App won best mobile app in the Charity/Non-Profit category of the 2018 Appy Awards. The annual Appy Awards are among the most distinguished awards in the app industry, dedicated to acknowledging creativity and excellence in app design across all platforms: mobile, social, and web-based.

“GRYT recognizes the value of building authentic human connections,” said Dave Fuehrer, co-founder and CEO of GRYT Health. “Connecting to others who ‘get it’ and building a strong, reliable network where patients, caregivers, and all stakeholders can contribute and be heard is critical to improving health outcomes and experiences. We are honored to be recognized for our work and incredibly thankful to the members of our community who are working hard alongside us to change the lives and futures of people impacted by cancer.”

Developed by GRYT Health and Fuzz, the GRYT App was launched in October 2017 and has over 500,000 user interactions making it the most used peer network and resource platform in oncology. The free mobile app, provides instant, anonymous peer support and tailored information to anyone affected by cancer including patients, survivors, caregivers, friends, family, medical professionals, researchers and advocates. Users complete a short profile and are connected with others based on the similarity of their experience. They can also participate in moderated group chats and programs hosted by experts in their field.

Please visit www.gryt.wpengine.com for more information or download the app from the iTunes App Store and Google Play store.

About the Appy Awards

MediaPost's Appy Awards honor creativity and excellence in app design. Celebrating its 21st anniversary, MediaPost Communications remains at the forefront of the ever-changing digital marketplace. It is the largest and most influential media, marketing, and advertising site providing news, blogs, and directories to help a community of more than 150,000 members better plan and buy both traditional and online advertising.

About GRYT Health

GRYT Health is a digital health start-up with a social purpose. Founded in 2016 by cancer survivors and caregivers, GRYT developed the GRYT App, a web-based mobile platform that is used in all 50 states and across 65 countries, to connect people with others just like them and with information to manage their health on their terms. GRYT works with organizations who specialize in oncology to ensure people have information and access to options, so they can choose what’s right for them.

At the 2018 SXSW Interactive Festival, GRYT Health was awarded a design consultation by the Design Institute for Health, a first-of-its-kind collaboration between Dell Medical School and the University of Texas at Austin. GRYT Health was also recognized as a runner-up in the SXSW HealthSpark Barracuda Bowl, a “shark tank” like pitch competition for innovative startups. In February 2018, GRYT Health was selected as runner-up for the Cambridge Healthtech Institute (CHI)’s 2018 Summit for Clinical Ops Executives (SCOPE) award, recognizing innovation and change in how the industry communicates with participants in the fields of recruitment and retention in clinical trials.

GRYT is headquartered in Rochester, NY. For more information, visit https://grythealth.com.

MEDIA CONTACT:

GRYT Health:

Vikki Christian, 424-610-1241
vikki@grythealth.com

May 14, 2018

GRYT Health’s GRYT App Named as Finalist in 2018 APPY Awards

ROCHESTER, N.Y.May 14, 2018 /PRNewswire/ -- GRYT Health, a digital health start-up with a social purpose today announced that its mobile platform, the GRYT App, has been selected as a finalist in the 2018 APPY Awards in the Charity/Non-Profit category. The APPY Awards, an annual program developed by Mediapost to honor creativity and excellence in app design, will announce its 2018 winners tomorrow, May 15th.

"As the oncology landscape evolves at an unprecedented rate with the acceleration of medicine and technology, it is becoming more difficult for patients and healthcare providers to keep up," said Dave Fuehrer, co-founder and CEO of GRYT Health. "Through the GRYT App, we are able to tailor information that helps users become more aware of options specific to their needs or diagnosis – empowering them to make choices that are right for them. We are honored to be recognized for our efforts in transforming the way technology can be used to support the cancer community."

Developed by GRYT Health and Fuzz, the GRYT App was launched in October 2017 and has over 500,000 user interactions making it the most used peer network and resource platform in oncology. The free mobile app, provides instant, anonymous peer support and tailored information to anyone affected by cancer including patients, survivors, caregivers, friends, family, medical professionals, researchers and advocates. Users complete a short profile and are connected with others based on the similarity of their experience. They can also participate in moderated group chats and programs hosted by experts in their field.

Please visit www.gryt.wpengine.com for more information or download the app from the iTunes App Store and Google Play store.

MediaPost's Appy Awards honor creativity and excellence in app design. Celebrating its 21st anniversary, MediaPost Communications remains at the forefront of the ever-changing digital marketplace. It is the largest and most influential media, marketing, and advertising site providing news, blogs, and directories to help a community of more than 150,000 members better plan and buy both traditional and online advertising.

About GRYT Health

GRYT Health is a digital health start-up with a social purpose. Founded in 2016 by cancer survivors and caregivers, GRYT developed the GRYT App, a web-based mobile platform that is used in all 50 states and across 50 countries, to connect people with others just like them and with information to manage their health on their terms. GRYT works with organizations who specialize in oncology to ensure people have information and access to options, so they can choose what's right for them.

At the 2018 SXSW Interactive Festival, GRYT Health was awarded a design consultation by the Design Institute for Health, a first-of-its-kind collaboration between Dell Medical School and the University of Texas at Austin. GRYT Health was also recognized as a runner-up in the SXSW HealthSpark Barracuda Bowl, a "shark tank" like pitch competition for innovative startups. In February 2018, GRYT Health was selected as runner-up for the Cambridge Healthtech Institute (CHI)'s 2018 Summit for Clinical Ops Executives (SCOPE) award, recognizing innovation and change in how the industry communicates with participants in the fields of recruitment and retention in clinical trials.

GRYT is headquartered in Rochester, NY. For more information, visit https://grythealth.com.

MEDIA CONTACT:

GRYT Health:

Vikki Christian, 424-610-1241
vikki@grythealth.com

SOURCE GRYT Health
Related Links
https://grythealth.com

March 13, 2018

GRYT Health and Bristol-Myers Squibb Announce New Digital Pilot to Advance Cancer Care through Patient-Driven Insights

GRYT Health and Bristol-Myers Squibb Announce New Digital Pilot to Advance
Cancer Care through Patient-Driven Insights

PR Newswire

ROCHESTER, N.Y. and PRINCETON, N.J., March 13, 2018

GRYT Health, a connected health start-up with a social purpose, and Bristol-Myers
Squibb Company (NYSE: BMY) today announced a strategic pilot utilizing
de-identified data to integrate patient insights and clinical research with
the goal of building a foundation of real-world data that will support
improved clinical trial design, disease management and the overall well-being
of patients living with cancer.

The pilot will provide Bristol-Myers Squibb with valuable insights from
patients on their experiences with cancer through GRYT's app,
the most used patient and caregiver platform in oncology. The app is designed
to instantly and anonymously connect people affected by cancer with each
other, give them a platform for exchange and empower them with important
resources and information. By learning more about how patients experience and
manage their disease, Bristol-Myers Squibb and GRYT aim to accelerate health
innovations and improve quality of life for patients.

"This pilot represents a shared commitment between GRYT Health and
Bristol-Myers Squibb to improve the lives of patients through collaboration
and digital innovation," said Dave Fuehrer, co-founder and CEO of GRYT Health.
"We worked with patients to build the GRYT app around their unique
preferences and expectations. Together with Bristol-Myers Squibb, we are
taking the same patient-driven approach to accelerate progress in the way we
manage disease and support the overall well-being for patients impacted by
cancer."

"Our primary focus is always on the patient," said Murdo Gordon, chief
commercial officer, Bristol-Myers Squibb. "Through our collaboration with
GRYT, we have the opportunity to incorporate the input of cancer patients
across our business – from research to patient support and empowerment
programs – that will best serve the cancer community."

"Today's technology has the potential to help us begin to close the gap
between patient experience and cancer research," said Kate Owen, head of
clinical operations, Bristol-Myers Squibb. "Through the GRYT app, we
are excited to learn more from patients about how we can make our clinical
research programs as patient-friendly as possible."

GRYT's App is a free mobile app that provides instant, anonymous peer
support and targeted cancer information to anyone affected by cancer including
patients, survivors, caregivers, friends, family, medical professionals,
researchers and advocates. Users complete a short profile and are connected
with others based on the similarity of their experience. They can also
participate in moderated group chats and programs hosted by experts in their
field. GRYT's App is available for free download for iOS devices and
for Android in April 2018.

At the 2018 SXSW Interactive Festival, GRYT Health was recognized as a
runner-up in the HealthSpark Barracuda Bowl, a "shark tank" like pitch
competition for innovative startups. GRYT was also selected as runner-up for
the Cambridge Healthtech Institute (CHI)'s 2018 Summit for Clinical Ops
Executives (SCOPE) award, recognizing innovation and change in how the
industry communicates with participants in the fields of recruitment and
retention in clinical trials.

About GRYT Health
GRYT Health is a Connected Health start-up with a social purpose. Founded in
2016 by cancer survivors and caregivers, GRYT developed the GRYT app,
a web-based mobile platform that is used in all 50 states and across 50
countries, to connect people with others just like them and with information
to manage their health on their terms. GRYT works with organizations who
specialize in oncology to ensure people have information and access to
options, so they can choose what's right for them. GRYT is
headquartered in Rochester, NY. For more information, visit
www.gryt.wpengine.com.

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or
follow us on Twitter at http://twitter.com/bmsnews.

CONTACT:

BRISTOL-MYERS SQUIBB
Media:
Danielle Halstrom, 215-280-3898
danielle.halstrom@bms.com

GRYT HEALTH
Media:
Vikki Christian, 424-610-1241
vikki@grythealth.com